Literature DB >> 6769420

The prophylactic use of antibiotics in alloarthroplasty of the hip joint for coxarthrosis.

K P Schulitz, W Winkelmann, B Schoening.   

Abstract

In alloarthroplasty of the hip joint due to coxarthrosis a randomized prospective controlled study was performed to test the efficiency of prophylactic antibiotics in reducing the postoperative infection rate. The minimum follow-up time was 730 days. There were three infections (two superficial and one deep) in the group who received antibiotics (105 patients), 10 infections (two superficial and eight deep) in the control group (89 patients). The overall rates of infections and also the rate of the deep wound infections were significantly lower in patients who received prophylactic antibiotics.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6769420     DOI: 10.1007/bf00433285

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0344-8444


  33 in total

1.  Prophylactic penicillin and streptomycin in elective operations on bones, joints and tendons.

Authors:  M L OLIX; T J KLUG; C R COLEMAN; W S SMITH
Journal:  Surg Forum       Date:  1960

2.  Deep wound sepsis following total hip arthroplasty.

Authors:  R H Fitzgerald; D R Nolan; D M Ilstrup; R E Van Scoy; J A Washington; M B Coventry
Journal:  J Bone Joint Surg Am       Date:  1977-10       Impact factor: 5.284

3.  [Secondary healing and antibiotic prevention in aseptic orthopedic operations].

Authors:  F Reichel
Journal:  Zentralbl Chir       Date:  1976       Impact factor: 0.942

4.  [Prevention of infection-disorders in wound healing. Collective report].

Authors:  K P Schulitz
Journal:  Z Orthop Ihre Grenzgeb       Date:  1977-08

5.  [Postoperative wound infections in orthopedic surgery (author's transl)].

Authors:  J Krämer; W Klein; M Steinhaus; G Lenz
Journal:  Arch Orthop Unfallchir       Date:  1974

6.  [Proceedings: Deep infections as a result of hip-joint replacement (author's transl)].

Authors:  H W Buchholz
Journal:  Langenbecks Arch Chir       Date:  1973

7.  The influence of antibiotic therapy on wound inflammation and sepsis associated with orthopaedic implants. A long-term clinical survey.

Authors:  J T Scales; A G Towers; B M Roantree
Journal:  Acta Orthop Scand       Date:  1972

8.  [Can one do without the prophylactic use of antibiotics in orthopedic surgery?].

Authors:  H J Fichtner
Journal:  Chirurg       Date:  1968-05       Impact factor: 0.955

9.  A comparison of dicloxacillin and ampicillin in the antibiotic prophylaxis of total hip replacement.

Authors:  T Visuri; P Antila; L E Laurent
Journal:  Ann Chir Gynaecol       Date:  1976

10.  Infection following total hip replacement in a general hospital without special orthopaedic facilities.

Authors:  M K Benson; S P Hughes
Journal:  Acta Orthop Scand       Date:  1975-12
View more
  5 in total

1.  Use of prophylactic antibiotics in orthopedic surgery.

Authors:  V Surin; E Borgström; L Bäckman
Journal:  Arch Orthop Trauma Surg       Date:  1982

Review 2.  Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures.

Authors:  William J Gillespie; Geert Him Walenkamp
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

Review 3.  Control strategies to prevent total hip replacement-related infections: a systematic review and mixed treatment comparison.

Authors:  Henry Zheng; Adrian G Barnett; Katharina Merollini; Alex Sutton; Nicola Cooper; Tony Berendt; Jennie Wilson; Nicholas Graves
Journal:  BMJ Open       Date:  2014-03-06       Impact factor: 2.692

Review 4.  Systematic review and meta-analysis of randomized controlled trials of antibiotics and antiseptics for preventing infection in people receiving primary total hip and knee prostheses.

Authors:  Jeffrey Voigt; Michael Mosier; Rabih Darouiche
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

Review 5.  Antibiotics and antiseptics for preventing infection in people receiving revision total hip and knee prostheses: a systematic review of randomized controlled trials.

Authors:  Jeffrey Voigt; Michael Mosier; Rabih Darouiche
Journal:  BMC Infect Dis       Date:  2016-12-12       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.